Regeneron quarterly profit drops as COVID antibody sales hit
(Reuters) -Regeneron Pharmaceuticals reported a 13% fall in quarterly profit on Wednesday, as sales of its COVID-19 antibody cocktail were hit by the U.S. health regulator's decision to limit its use.

04-05-2022